Anemia Research Today is a free monthly online journal that collates and summarizes the latest research about Anemia, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 2 (2005), Issue 2 (February)

1. Familial aggregation of cerebral malaria and severe malarial anemia.
   J Infect Dis, 191(5): 799-804. [Abstract] [Full-text]
2. Anemia is a poor predictor of iron deficiency among toddlers in the United States: for heme the bell tolls.
   Pediatrics, 115(2): 315-20. [Abstract] [Full-text]
3. Are HLA antigens a risk factor for acute GVHD in thalassemic patients receiving HLA-identical stem cell transplantation?
   Transplant Proc, 36(10): 3190-3. [Abstract] [Full-text]
4. Effect of tacrolimus in a patient with pure red-cell aplasia.
   Clin Lab Haematol, 27(1): 67-9. [Abstract] [Full-text]
5. Immunocytometric quantitation of foeto-maternal haemorrhage with the Abbott Cell-Dyn CD4000 haematology analyser.
   Clin Lab Haematol, 27(1): 21-31. [Abstract] [Full-text]
6. The impact of anaemia on outcome in cancer.
   Clin Lab Haematol, 27(1): 1-13. [Abstract] [Full-text]
7. Childhood paroxysmal nocturnal haemoglobinuria (PNH), a report of 11 cases in the Netherlands.
   Br J Haematol, 128(4): 571-7. [Abstract] [Full-text]
8. 5-hydroxymethyl-2-furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells.
   Br J Haematol, 128(4): 552-61. [Abstract] [Full-text]
9. Cervical length as a prognostic factor for preterm delivery in twin-to-twin transfusion syndrome treated by fetoscopic laser coagulation of chorionic plate anastomoses.
   Ultrasound Obstet Gynecol, 25(1): 37-41. [Abstract] [Full-text]
10. Predictive risk factors and prevalence of malignancy in patients with iron deficiency anemia in Taiwan.
    Am J Hematol, 78(2): 108-12. [Abstract] [Full-text]
11. Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab.
    Am J Hematol, 78(2): 123-6. [Abstract] [Full-text]
12. Use of an implantable drug delivery system for refractory chronic sickle cell pain.
    Am J Hematol, 78(2): 153-4. [Abstract] [Full-text]
13. Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia.
    Blood, 105(4): 1797-802. [Abstract] [Full-text]
14. Acquired hemoglobin H disease in a patient with aplastic anemia evolving into acute myeloid leukemia.
    Sao Paulo Med J, 122(6): 273-5. [Abstract] [Full-text]
15. Acute myocardial infarction in sickle cell disease: a possible complication of hydroxyurea treatment.
    Hematol J, 5(7): 589-90. [Abstract] [Full-text]
16. The effect of iron deficiency anemia on the function of the immune system.
    Hematol J, 5(7): 579-83. [Abstract] [Full-text]
17. Iron deficiency anemia in patients without gastrointestinal symptoms--a prospective study.
    Fam Pract, 22(1): 58-61. [Abstract] [Full-text]
18. Can peak systolic velocities be used for prediction of stroke in sickle cell anemia?
    Pediatr Radiol, 35(1): 66-72. [Abstract] [Full-text]
19. A young girl with hemolytic anemia and elevated hemoglobin F.
    Pediatr Blood Cancer, 44(3): 264-6. [Abstract] [Full-text]
20. Transcranial Doppler imaging in children: sickle cell screening and beyond.
    Pediatr Radiol, 35(1): 54-65. [Abstract] [Full-text]
21. Persistent elevation of cell-free fetal DNA levels in maternal plasma after selective laser coagulation of chorionic plate anastomoses in severe midgestational twin-twin transfusion syndrome.
    Am J Obstet Gynecol, 192(2): 604-9. [Abstract] [Full-text]
22. An explanation for the efficacy of procaine in the treatment of sickle cell anaemia.
    Int J Biochem Cell Biol, 37(4): 835-41. [Abstract] [Full-text]
23. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway.
    Mol Cell, 17(3): 331-9. [Abstract] [Full-text]
24. Psychosocial implications of Thalassemia Major.
    Pediatr Int, 47(1): 84-9. [Abstract] [Full-text]
25. Recombinant human erythropoietin therapy in low-birthweight preterm infants: a prospective controlled study.
    Pediatr Int, 47(1): 67-71. [Abstract] [Full-text]
26. Thrombotic microangiopathy after combined autografting-allografting for multiple myeloma - report of three cases.
    Eur J Haematol, 74(3): 250-3. [Abstract] [Full-text]
27. Safety of oral iron chelator deferiprone in young thalassaemics.
    Eur J Haematol, 74(3): 217-20. [Abstract] [Full-text]
28. Exploring strategies for the design of artificial transcription factors: targeting sites proximal to known regulatory regions for the induction of gamma-globin expression and the treatment of sickle cell disease.
    J Biol Chem, 280(5): 3707-14. [Abstract] [Full-text]
29. Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome.
    Ann Hematol, 84(3): 167-76. [Abstract] [Full-text]
30. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin.
    Ann Hematol, 84(3): 159-66. [Abstract] [Full-text]
31. Characterization of red cell autoantibodies in consecutive DAT-positive patients with relation to in vivo haemolysis.
    Ann Hematol, 84(3): 150-8. [Abstract] [Full-text]
32. Fludarabine-based conditioning for allogeneic stem cell transplantation for multiply transfused patients with Fanconi's anemia.
    Bone Marrow Transplant, 35(4): 341-3. [Abstract] [Full-text]
33. Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion.
    Bone Marrow Transplant, 35(4): 369-73. [Abstract] [Full-text]
34. Efficacy of lenalidomide in myelodysplastic syndromes.
    N Engl J Med, 352(6): 549-57. [Abstract] [Full-text]
35. Severe autoimmune hemolytic anemia treated by paralysis, induced hypothermia, and splenic embolization.
    Chest, 127(2): 678-81. [Abstract] [Full-text]
36. Biochemical markers of bone turnover and bone mineral density in patients with beta-thalassaemia major.
    Int J Clin Pract, 59(1): 46-51. [Abstract] [Full-text]
37. The study of anaemia-related haemostasis impairment in haemodialysis patients by in vitro closure time test.
    Thromb Haemost, 93(2): 375-9. [Abstract] [Full-text]
38. "Dub"bing a tumor suppressor pathway.
    Cancer Cell, 7(2): 114-5. [Abstract] [Full-text]
39. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma.
    JAMA, 293(7): 843-9. [Abstract] [Full-text]
40. Potential approaches to prevent uncommon hemolytic side effects of AB0 antibodies in plasma derivatives.
    Biologicals, 33(1): 41-8. [Abstract] [Full-text]
41. High frequency of partial DIIIa and DAR alleles found in sickle cell disease patients suggests increased risk of alloimmunization to RhD.
    Transfus Med, 15(1): 49-55. [Abstract] [Full-text]
42. Impaired vasodilation by red blood cells in sickle cell disease.
    Proc Natl Acad Sci U S A, 102(7): 2531-6. [Abstract] [Full-text]
43. Understanding the shape of sickled red cells.
    Biophys J, 88(2): 1371-6. [Abstract] [Full-text]
44. Serum carnitine levels in patients with homozygous beta thalassemia: a possible new role for carnitine?
    Eur J Pediatr, 164(3): 131-4. [Abstract] [Full-text]
45. Iron prophylaxis during pregnancy -- how much iron is needed? A randomized dose- response study of 20-80 mg ferrous iron daily in pregnant women.
    Acta Obstet Gynecol Scand, 84(3): 238-47. [Abstract] [Full-text]
46. The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability.
    Hum Mol Genet, 14(5): 693-701. [Abstract] [Full-text]
47. Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.
    Hum Mol Genet, 14(5): 703-12. [Abstract] [Full-text]
48. zeta-/- Thalassemic mice are affected by two modifying loci and display unanticipated somatic recombination leading to inherited variation.
    Hum Mol Genet, 14(5): 615-25. [Abstract] [Full-text]
49. Exhaled carbon monoxide levels in children with sickle cell disease.
    Eur J Pediatr, 164(3): 162-5. [Abstract] [Full-text]
50. Cytologic features of renal medullary carcinoma.
    Cancer, 105(1): 28-34. [Abstract] [Full-text]
51. The Corfu deltabeta thalassemia deletion disrupts gamma-globin gene silencing and reveals post-transcriptional regulation of HbF expression.
    Blood, 105(5): 2154-60. [Abstract] [Full-text]
52. A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain.
    Blood, 105(5): 1946-9. [Abstract] [Full-text]
53. Positional cloning of the Ttc7 gene required for normal iron homeostasis and mutated in hea and fsn anemia mice.
    Genomics, 85(3): 330-7. [Abstract] [Full-text]
54. Alleviation of hemolysis after the stent implantation into an obstructed extracardiac conduit.
    Int J Cardiol, 99(1): 135-6. [Abstract] [Full-text]
55. Simplified hemoglobin chain detection by capillary electrophoresis.
    Electrophoresis, 26(3): 581-5. [Abstract] [Full-text]
56. Neonatal bilirubin production-conjugation imbalance: effect of glucose-6-phosphate dehydrogenase deficiency and borderline prematurity.
    Arch Dis Child Fetal Neonatal Ed, 90(2): F123-7. [Abstract] [Full-text]
57. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
    Leuk Res, 29(4): 371-9. [Abstract] [Full-text]
58. Lack of prognostic value of normalized integrated backscatter analysis of myocardium in patients with thalassemia major: a long-term follow-up study.
    Echocardiography, 22(3): 239-44. [Abstract] [Full-text]
59. Heterogeneity of the epsilon gamma delta beta-thalassaemias: characterization of three novel English deletions.
    Br J Haematol, 128(5): 722-9. [Abstract] [Full-text]
60. Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation.
    Br J Haematol, 128(5): 668-75. [Abstract] [Full-text]
61. Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning.
    Bone Marrow Transplant, 35(5): 467-71. [Abstract] [Full-text]
62. Stem cell transplantation for patients with Fanconi anemia with low-dose cyclophosphamide and antithymocyte globulins without the use of radiation therapy.
    Bone Marrow Transplant, 35(5): 463-6. [Abstract] [Full-text]
63. Flow cytometric evaluation of bound IgG on erythrocytes of anaemic dogs.
    Vet J, 169(2): 303-7. [Abstract] [Full-text]
64. Intra-leukocytic hemosiderin inclusions detected as pseudoeosinophils by automated depolarization analysis in a patient with beta-thalassaemia major and immune hemolysis.
    Blood Cells Mol Dis, 34(2): 162-5. [Abstract] [Full-text]
65. A woman with 46,XX,dup(16)(p13.11 p13.3) and the ATR-X phenotype.
    Am J Med Genet A, 132(4): 414-8. [Abstract] [Full-text]
66. Alpha-thalassemia/mental retardation syndrome in a 45,X male.
    Am J Med Genet A, 132(4): 431-3. [Abstract] [Full-text]
67. TNF-alpha mediates the development of anaemia in a murine Trypanosoma brucei rhodesiense infection, but not the anaemia associated with a murine Trypanosoma congolense infection.
    Clin Exp Immunol, 139(3): 405-10. [Abstract] [Full-text]
68. Myelodysplastic syndrome with erythroid hypoplasia.
    J Clin Pathol, 58(3): 320-1. [Abstract] [Full-text]
69. An Ashkenazi Jewish woman presenting with favism.
    J Clin Pathol, 58(3): 317-9. [Abstract] [Full-text]
70. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.
    Cancer Res, 65(4): 1271-6. [Abstract] [Full-text]

© 2004-2008 Anemia Research Today. All Rights Reserved.